Workflow
Sotera Health(SHC)
icon
Search documents
Firstlight Management Calls on the Board of Directors of Sotera Health Company to Launch Sale Process for Nelson Labs
Prnewswire· 2024-12-18 12:00
NEW YORK, Dec. 18, 2024 /PRNewswire/ -- On December 3, 2024, Firstlight Management LP sent a letter to the Board of Directors of Sotera Health Company (NASDAQ: SHC) calling for a sale of its Nelson Labs subsidiary. The full text of the letter is as follows: Dear Members of the Board, As you know, Firstlight Management is a Utah-based investment firm founded by an alumnus of Tiger Management and Leonard Green & Partners. We are shareholders of Sotera Health ("SHC") and believe so strongly in the potential at ...
Sotera Health to Share Next Chapter of Growth at 2024 Investor Day
GlobeNewswire News Room· 2024-11-20 14:00
CLEVELAND, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, will hold an Investor Day in New York City where Sotera Health’s management team will discuss the Company’s strategic positioning and outline future growth plans. Management will take questions from a live audience during two question-and-answer sessions. “The management team is lo ...
Sotera Health (SHC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2024-11-05 16:01
Sotera Health Company (SHC) reported $285.47 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 8.5%. EPS of $0.17 for the same period compares to $0.21 a year ago.The reported revenue represents a surprise of +2.05% over the Zacks Consensus Estimate of $279.73 million. With the consensus EPS estimate being $0.19, the EPS surprise was -10.53%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectatio ...
Sotera Health Company (SHC) Q3 Earnings Lag Estimates
ZACKS· 2024-11-05 14:25
Sotera Health Company (SHC) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.21 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -10.53%. A quarter ago, it was expected that this company would post earnings of $0.17 per share when it actually produced earnings of $0.19, delivering a surprise of 11.76%.Over the last four quarters, the co ...
Sotera Health Announces Secondary Offering of Common Stock
GlobeNewswire News Room· 2024-09-04 20:41
CLEVELAND, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the "Company") today announced the launch of a secondary offering (the "Offering") of 25,000,000 shares of its common stock, par value $0.01 per share. All 25,000,000 shares are being offered for sale by certain affiliates of Warburg Pincus LLC ("Warburg Pincus") and GTCR LLC ("GTCR") as selling stockholders. No other entities, and no individuals, are selling shares in the Offering. It is expected that, as a result of the Off ...
Sotera Health(SHC) - 2024 Q2 - Earnings Call Transcript
2024-08-05 18:44
Sotera Health Company (NASDAQ:SHC) Q2 2024 Earnings Conference Call August 5, 2024 9:00 AM ET Company Participants Jason Peterson - VP & Treasurer Michael Petras - Chairman & CEO Jonathan Lyons - SVP & CFO Conference Call Participants Dave Windley - Jefferies Brett Fishbin - KeyBanc Capital Markets Patrick Donnelly - Citigroup Inc. Casey Woodring - J.P. Morgan Chase Salem Salem - Barclays Jason Bednar - Piper Sandler Michael Polark - Wolfe Research Operator Good morning, and welcome to the Sotera Health Sec ...
Sotera Health Reports Second-Quarter and First-Half 2024 Results
GlobeNewswire News Room· 2024-08-05 11:00
Core Insights - Sotera Health Company reported Q2 2024 net revenues of $277 million, an increase of 8% compared to Q2 2023, with a constant currency increase of 8.8% [2][3] - The net income for Q2 2024 was $9 million, or $0.03 per diluted share, down from $24 million, or $0.08 per diluted share in Q2 2023, primarily due to refinancing charges [2][3] - Adjusted EBITDA for Q2 2024 was $137 million, a 6.9% increase from $128 million in Q2 2023, while Adjusted EPS decreased by $0.01 to $0.19 [2][3] Financial Performance - For the first six months of 2024, net revenues rose 10.3% to $525 million from $476 million in the same period of 2023, with a constant currency increase of approximately 10.2% [3] - Net income for the first half of 2024 was $15 million, or $0.05 per diluted share, compared to $26 million, or $0.09 per diluted share in the prior year [3] - Adjusted EBITDA for the first half of 2024 increased by 9.8% to $249 million, while Adjusted EPS decreased by $0.01 to $0.32 [3] Business Segment Review - Sterigenics reported Q2 2024 net revenues of $176 million, a 5.9% increase year-over-year, with segment income rising 5.8% to $97 million [4][5] - Nordion experienced significant growth, with Q2 2024 net revenues of $41 million, a 29% increase, and segment income up 31.7% to $23 million [6][7] - Nelson Labs saw Q2 2024 net revenues of $59 million, a 4% increase, but segment income decreased by 11% to $17 million [8][9] Debt and Liquidity - As of June 30, 2024, Sotera Health had total debt of $2.3 billion and $246 million in unrestricted cash, down from $296 million at the end of 2023 [10][28] - The company successfully refinanced its debt structure, extending maturities to 2031 [11] - The Net Leverage Ratio as of June 30, 2024, was 3.8x [10][37] 2024 Outlook - Sotera Health reaffirmed its 2024 outlook, expecting net revenues and Adjusted EBITDA growth in the range of 4% to 6% [12][13] - Interest expense is projected to be between $165 million and $175 million, with Adjusted EPS expected in the range of $0.67 to $0.75 [12][13]
Sotera Health Appoints Christopher Simon to the Board of Directors
GlobeNewswire News Room· 2024-08-01 11:00
Core Insights - Sotera Health Company has appointed Christopher Simon as a new independent director to its Board of Directors, enhancing its leadership team [1][3] - Mr. Simon brings over 30 years of experience in the healthcare industry, including roles as President and CEO of Haemonetics Corporation and Senior Partner at McKinsey & Company [2][3] - Sotera Health operates through three business units: Sterigenics®, Nordion®, and Nelson Labs®, focusing on sterilization solutions and lab testing services for the healthcare sector [4] Company Overview - Sotera Health is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry [4] - The company is committed to its mission of "Safeguarding Global Health®" [4] Leadership Experience - Christopher Simon's leadership experience as a public company CEO and his strategic background in the life sciences industry are expected to be significant assets for Sotera Health's growth [3] - Mr. Simon also serves on the board of directors of AdvaMed, a global trade association for medical technology companies [3]
Sotera Health Announces Second-Quarter 2024 Earnings Release Date
Newsfilter· 2024-07-22 21:00
Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company's website at Investor Relations | Sotera Health. For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health. Contacts Source: Sotera Health Company To participate in the live call, please dial 1-844-481-2916 if dialing-in from the United States, or 1-412-317- 0709 if dialing-in from other locations. A live webcast of the confe ...
Sotera Health Announces Second-Quarter 2024 Earnings Release Date
GlobeNewswire News Room· 2024-07-22 21:00
To participate in the live call, please dial 1-844-481-2916 if dialing-in from the United States, or 1-412-317- 0709 if dialing-in from other locations. A live webcast of the conference call can be accessed at this link or via the Investor Relations section of the Company's website at Presentation & Events | Sotera Health, along with the accompanying materials. A replay of the webcast will be available later in the day on August 5th. Jason Peterson Vice President & Treasurer, Sotera Health IR@soterahealth.c ...